148 related articles for article (PubMed ID: 18681120)
1. [Reproductive choices in women living with HIV/AIDS in the era of highly active antiretroviral therapies (HAART)].
Heard I; Sitta R; Lert F;
Med Sci (Paris); 2008 Mar; 24 Spec No 2():48-52. PubMed ID: 18681120
[No Abstract] [Full Text] [Related]
2. Awareness and attitude of health workers at a Nigerian HIV treatment clinic toward HIV/AIDS and HAART adherence.
Olowookere SA; Fatiregun AA; Osagbemi KG
J Int Assoc Physicians AIDS Care (Chic); 2009; 8(3):208-12. PubMed ID: 19357425
[TBL] [Abstract][Full Text] [Related]
3. Quality of life and its correlates in HIV/AIDS male outpatients receiving highly active antiretroviral therapy in Taiwan.
Yen CF; Tsai JJ; Lu PL; Chen YH; Chen TC; Chen PP; Chen TP
Psychiatry Clin Neurosci; 2004 Oct; 58(5):501-6. PubMed ID: 15482581
[TBL] [Abstract][Full Text] [Related]
4. Delayed progression to death and to AIDS in a Hong Kong cohort of patients with advanced HIV type 1 disease during the era of highly active antiretroviral therapy.
Wong KH; Chan KC; Lee SS
Clin Infect Dis; 2004 Sep; 39(6):853-60. PubMed ID: 15472819
[TBL] [Abstract][Full Text] [Related]
5. Impact of highly active antiretroviral therapy on the incidence of visceral leishmaniasis in a French cohort of patients infected with human immunodeficiency virus.
del Giudice P; Mary-Krause M; Pradier C; Grabar S; Dellamonica P; Marty P; Gastaut JA; Costagliola D; Rosenthal E;
J Infect Dis; 2002 Nov; 186(9):1366-70. PubMed ID: 12402211
[TBL] [Abstract][Full Text] [Related]
6. [HIV associated encephalopathy after highly active antiretroviral therapy (HAART)].
Kishida S
No To Shinkei; 2004 Apr; 56(4):301-10. PubMed ID: 15237721
[No Abstract] [Full Text] [Related]
7. Pregnancy and HIV disease progression during the era of highly active antiretroviral therapy.
Tai JH; Udoji MA; Barkanic G; Byrne DW; Rebeiro PF; Byram BR; Kheshti A; Carter JD; Graves CR; Raffanti SP; Sterling TR
J Infect Dis; 2007 Oct; 196(7):1044-52. PubMed ID: 17763327
[TBL] [Abstract][Full Text] [Related]
8. Activation and coreceptor expression of T lymphocytes induced by highly active antiretroviral therapy in Chinese HIV/AIDS patients.
Zhang ZN; Shang H; Jiang YJ; Liu J; Dai D; Diao YY; Geng WQ; Jin X; Wang YN
Chin Med J (Engl); 2006 Dec; 119(23):1966-71. PubMed ID: 17199940
[TBL] [Abstract][Full Text] [Related]
9. An exploration of factors influencing adherence to highly active anti-retroviral therapy (HAART) among people living with HIV/AIDS in Northern Thailand.
Ruanjahn G; Roberts D; Monterosso L
AIDS Care; 2010 Dec; 22(12):1555-61. PubMed ID: 20582752
[TBL] [Abstract][Full Text] [Related]
10. An examination of HIV/AIDS patients who have excellent adherence to HAART.
Malcolm SE; Ng JJ; Rosen RK; Stone VE
AIDS Care; 2003 Apr; 15(2):251-61. PubMed ID: 12856346
[TBL] [Abstract][Full Text] [Related]
11. [Safety study of 52-week highly active antiretroviral therapy in 198 HIV/AIDS Chinese patients].
Li WJ; Dai Y; Han Y; Qiu ZF; Xie J; Zuo LY; Li YL; Li TS
Zhonghua Yi Xue Za Zhi; 2011 May; 91(19):1318-22. PubMed ID: 21756757
[TBL] [Abstract][Full Text] [Related]
12. AIDS malignancies in the era of highly active antiretroviral therapy.
Gates AE; Kaplan LD
Oncology (Williston Park); 2002 May; 16(5):657-65; discussion 665, 668-70. PubMed ID: 12108891
[TBL] [Abstract][Full Text] [Related]
13. The impact of integrating food supplementation, nutritional education and HAART (Highly Active Antiretroviral Therapy) on the nutritional status of patients living with HIV/AIDS in Mozambique: results from the DREAM Programme.
Scarcella P; Buonomo E; Zimba I; Doro Altan AM; Germano P; Palombi L; Marazzi MC
Ig Sanita Pubbl; 2011; 67(1):41-52. PubMed ID: 21468153
[TBL] [Abstract][Full Text] [Related]
14. Malignancy-related causes of death in human immunodeficiency virus-infected patients in the era of highly active antiretroviral therapy.
Bonnet F; Lewden C; May T; Heripret L; Jougla E; Bevilacqua S; Costagliola D; Salmon D; Chêne G; Morlat P
Cancer; 2004 Jul; 101(2):317-24. PubMed ID: 15241829
[TBL] [Abstract][Full Text] [Related]
15. Factors associated with the occurrence of AIDS-related non-Hodgkin lymphoma in the era of highly active antiretroviral therapy: Aquitaine Cohort, France.
Bonnet F; Balestre E; Thiébaut R; Morlat P; Pellegrin JL; Neau D; Dabis F;
Clin Infect Dis; 2006 Feb; 42(3):411-7. PubMed ID: 16392091
[TBL] [Abstract][Full Text] [Related]
16. An adherence typology: coping, quality of life, and physical symptoms of people living with HIV/AIDS and their adherence to antiretroviral treatment.
Bader A; Kremer H; Erlich-Trungenberger I; Rojas R; Lohmann M; Deobald O; Lochmann R; Altmeyer P; Brockmeyer N
Med Sci Monit; 2006 Dec; 12(12):CR493-500. PubMed ID: 17136004
[TBL] [Abstract][Full Text] [Related]
17. Clinical manifestations of treatment-naive patients with acquired immunodeficiency syndrome and responses to highly active antiretroviral therapy in the Taipei Veterans General Hospital: a 5-year prospective study.
Hsu SF; Yang SP; Chan YJ; Wang YW
J Microbiol Immunol Infect; 2011 Jun; 44(3):198-203. PubMed ID: 21524614
[TBL] [Abstract][Full Text] [Related]
18. [Award of the 2003 AIDS Prize. Why doesn HAART therapy induce lipodystrophy in HIV positive patients?].
HNO; 2003 Jul; 51(7):543. PubMed ID: 12916494
[No Abstract] [Full Text] [Related]
19. Challenges in the management of the HIV patient in the third decade of AIDS.
Tiamson ML
Psychiatr Q; 2002; 73(1):51-8. PubMed ID: 11780598
[TBL] [Abstract][Full Text] [Related]
20. A resurgent HIV-1 epidemic among men who have sex with men in the era of potent antiretroviral therapy.
Bezemer D; de Wolf F; Boerlijst MC; van Sighem A; Hollingsworth TD; Prins M; Geskus RB; Gras L; Coutinho RA; Fraser C
AIDS; 2008 May; 22(9):1071-7. PubMed ID: 18520351
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
